{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:20:41Z","timestamp":1752549641808,"version":"3.40.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12185-025-03930-4","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:52:01Z","timestamp":1738209121000},"page":"553-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Steroid-resistant nephrotic syndrome due to renal-limited thrombotic microangiopathy and membranous nephropathy after allogeneic hematopoietic stem cell transplantation successfully treated with calcineurin inhibitors"],"prefix":"10.1007","volume":"121","author":[{"given":"Shinri","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6183-8910","authenticated-orcid":false,"given":"Masashi","family":"Nishikubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"3930_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2215\/CJN.00620117","volume":"13","author":"V Brocklebank","year":"2018","unstructured":"Brocklebank V, Wood KM, Kavanagh D. Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol. 2018;13:300\u201317. https:\/\/doi.org\/10.2215\/CJN.00620117.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3930_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90:918\u201326. https:\/\/doi.org\/10.1097\/TP.0b013e3181f24e8d.","journal-title":"Transplantation"},{"key":"3930_CR3","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","volume":"122","author":"S Jodele","year":"2013","unstructured":"Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood. 2013;122:2003\u20137. https:\/\/doi.org\/10.1182\/blood-2013-05-501445.","journal-title":"Blood"},{"key":"3930_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:571\u20135. https:\/\/doi.org\/10.1016\/j.bbmt.2005.06.001.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3930_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124:645\u201353. https:\/\/doi.org\/10.1182\/blood-2014-03-564997.","journal-title":"Blood"},{"key":"3930_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1053\/j.ajkd.2018.06.013","volume":"72","author":"R Wanchoo","year":"2018","unstructured":"Wanchoo R, Bayer RL, Bassil C, Jhaveri KD. Emerging concepts in hematopoietic stem cell transplantation-associated renal thrombotic microangiopathy and prospects for new treatments [published correction appears in Am J Kidney Dis 2019;73(2):291. 10.1053\/j.ajkd.2018.11.002]. Am J Kidney Dis. 2018;72:857\u201365. https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.013.","journal-title":"Am J Kidney Dis"},{"key":"3930_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","volume":"81","author":"DS Genest","year":"2023","unstructured":"Genest DS, Patriquin CJ, Licht C, John R, Reich HN. Renal thrombotic microangiopathy: a review. Am J Kidney Dis. 2023;81:591\u2013605. https:\/\/doi.org\/10.1053\/j.ajkd.2022.10.014.","journal-title":"Am J Kidney Dis"},{"key":"3930_CR8","doi-asserted-by":"publisher","first-page":"E426","DOI":"10.1002\/ajh.26705","volume":"97","author":"G Bhutani","year":"2022","unstructured":"Bhutani G, Leung N, Said SM, Valeri AM, Astor BC, Fidler ME, Alexander MP, Cornell LD, Nasr SH. The prevalence and clinical outcomes of microangiopathic hemolytic anemia in patients with biopsy-proven renal thrombotic microangiopathy. Am J Hematol. 2022;97:E426\u20139. https:\/\/doi.org\/10.1002\/ajh.26705.","journal-title":"Am J Hematol"},{"key":"3930_CR9","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1182\/blood-2018-99-117723","volume":"132","author":"ES Saba","year":"2018","unstructured":"Saba ES, Cambron JC, Go RS, Leung N, Sridharan M. Clinical associations, treatment, and outcomes of renal-limited thrombotic microangiopathy. Blood. 2018;132:4978. https:\/\/doi.org\/10.1182\/blood-2018-99-117723.","journal-title":"Blood"},{"key":"3930_CR10","doi-asserted-by":"publisher","first-page":"100690","DOI":"10.1016\/j.modpat.2024.100690","volume":"38","author":"DPC van Doorn","year":"2024","unstructured":"van Doorn DPC, Tobal R, Abdul-Hamid MA, van Paassen P, Timmermans SAMEG. Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy. Mod Pathol. 2024;38:100690. https:\/\/doi.org\/10.1016\/j.modpat.2024.100690.","journal-title":"Mod Pathol"},{"key":"3930_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","volume":"41","author":"J Schwimmer","year":"2003","unstructured":"Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Zand MS. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis. 2003;41:471\u20139. https:\/\/doi.org\/10.1053\/ajkd.2003.50058.","journal-title":"Am J Kidney Dis"},{"key":"3930_CR12","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","volume":"55","author":"A Zarifian","year":"1999","unstructured":"Zarifian A, Meleg-Smith S, O\u2019donovan R, Tesi RJ, Batuman V. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int. 1999;55:2457\u201366. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00492.x.","journal-title":"Kidney Int"},{"key":"3930_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12882-018-1194-9","volume":"20","author":"R Yamada","year":"2019","unstructured":"Yamada R, Okawa T, Matsuo K, Suzuki M, Mori N, Mori K. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report. BMC Nephrol. 2019;20:14. https:\/\/doi.org\/10.1186\/s12882-018-1194-9.","journal-title":"BMC Nephrol"},{"key":"3930_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12882-021-02386-y","volume":"22","author":"M Nishikubo","year":"2021","unstructured":"Nishikubo M, Shimomura Y, Hiramoto N, Sawamura N, Yamaguchi T, Hara S, et al. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report. BMC Nephrol. 2021;22:175. https:\/\/doi.org\/10.1186\/s12882-021-02386-y.","journal-title":"BMC Nephrol"},{"key":"3930_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ekir.2017.12.013","volume":"3","author":"A Mii","year":"2018","unstructured":"Mii A, Shimizu A, Kaneko T, Nakayama K, Yamaguchi H, Tsuruoka S. Renal thrombotic microangiopathy after hematopoietic stem cell transplantation: involvement of chronic graft-versus-host disease. Kidney Int Rep. 2018;3:743\u20137. https:\/\/doi.org\/10.1016\/j.ekir.2017.12.013.","journal-title":"Kidney Int Rep"},{"key":"3930_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/pin.12589","volume":"67","author":"N Masuzawa","year":"2017","unstructured":"Masuzawa N, Nishimura A, Kitani T, Tamagaki K, Sugitani M, Nagoshi H, et al. A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy. Pathol Int. 2017;67:620\u20135. https:\/\/doi.org\/10.1111\/pin.12589.","journal-title":"Pathol Int"},{"key":"3930_CR17","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMra1404711","volume":"374","author":"S Hingorani","year":"2016","unstructured":"Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med. 2016;374:2256\u201367. https:\/\/doi.org\/10.1056\/NEJMra1404711.","journal-title":"N Engl J Med"},{"key":"3930_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.bbmt.2015.12.014","volume":"22","author":"O Beyar-Katz","year":"2016","unstructured":"Beyar-Katz O, Davila EK, Zuckerman T, Fineman R, Haddad N, Okasha D, et al. Adult nephrotic syndrome after hematopoietic stem cell transplantation: renal pathology is the best predictor of response to therapy. Biol Blood Marrow Transplant. 2016;22:975\u201381. https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.014.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3930_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100674","volume":"5","author":"G Roy","year":"2023","unstructured":"Roy G, Iordachescu I, Royal V, Lamarche C, Ahmad I, Nadeau-Fredette AC, et al. Kidney biopsy findings among allogenic hematopoietic stem cell transplant recipients with kidney injury: a case series. Kidney Med. 2023;5: 100674. https:\/\/doi.org\/10.1016\/j.xkme.2023.100674.","journal-title":"Kidney Med"},{"key":"3930_CR20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1046\/j.1365-2141.2002.03721.x","volume":"118","author":"T Ruutu","year":"2002","unstructured":"Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 2002;118:1112\u20139. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03721.x.","journal-title":"Br J Haematol"},{"key":"3930_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.bmt.1705446","volume":"38","author":"P Reddy","year":"2006","unstructured":"Reddy P, Johnson K, Uberti JP, Reynolds C, Silver S, Ayash L, et al. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;38:351\u20137. https:\/\/doi.org\/10.1038\/sj.bmt.1705446.","journal-title":"Bone Marrow Transplant"},{"key":"3930_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","volume":"21","author":"A Tichelli","year":"2008","unstructured":"Tichelli A, Gratwohl A. Vascular endothelium as \u2018novel\u2019 target of graft-versus-host disease. Best Pract Res Clin Haematol. 2008;21:139\u201348. https:\/\/doi.org\/10.1016\/j.beha.2008.02.002.","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-03930-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:18:00Z","timestamp":1742390280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-03930-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3930"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-03930-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial or proprietary interests in any of the materials discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As the patients provided written consent for the publication of this case, no ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent was obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}}]}}